PCI: Too Hard To Handle – EU Clinical Trials Seminar
Join PCI for a complimentary educational lunch event The face of clinical trials is constantly changing with more challenges for drug developers than ever. Two core themes define this, new and evolving technologies, and more difficult disease targets. Compounds for these targets tend to be riskier to develop and more expensive to produce. With this in mind...